ChemoCentryx Inc. (CCXI) Soars 1.28% on January 13

Equities Staff  |

ChemoCentryx Inc. (CCXI) had a good day on the market for Wednesday January 13 as shares jumped 1.28% to close at $61.71. About 379,116 shares traded hands on 4,611 trades for the day, compared with an average daily volume of n/a shares out of a total float of 69.21 million. After opening the trading day at $61.14, shares of ChemoCentryx Inc. stayed within a range of $61.90 to $60.10.

With today's gains, ChemoCentryx Inc. now has a market cap of $4.27 billion. Shares of ChemoCentryx Inc. have been trading within a range of $65.44 and $30.72 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.

ChemoCentryx Inc is a biopharmaceutical company involved in discovery, development, and commercialization of orally administered drugs to treat rare diseases, inflammatory disorders, autoimmune diseases, and cancer. The company's approach is to target the chemoattractant system, defined as a network of molecules (for example, chemokine ligands, their associated receptors, and chemoattractant receptors) known to cause inflammation. The targeted therapeutic areas are an antineutrophil cytoplasmic antibody, atypical hemolytic uremic syndrome, immunoglobulin A-mediated nephropathy (rare diseases category), pancreatic cancer, chronic kidney disease, psoriasis, rheumatoid arthritis, asthma, Crohn's disease, inflammatory bowel disease, and others.

ChemoCentryx Inc. is based out of Mountain View, CA and has some 82 employees. Its CEO is Thomas J. Schall.

For a complete fundamental analysis of ChemoCentryx Inc., check out’s Stock Valuation Analysis report for CCXI.

Still paying commissions on stock trades? now offers $7.99/month unlimited trading and flat-fee options trading for $89.99/month! Get started today by

ChemoCentryx Inc. is also a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

To get more information on ChemoCentryx Inc. and to follow the company’s latest updates, you can visit the company’s profile page here: CCXI’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit’s Newsdesk. Also, don’t forget to sign-up for our daily email newsletter to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:



Symbol Last Price Change % Change